Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid cancer, medullary × lenvatinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Carcinoma, Renal Cell 10 Endometrial Neoplasms 7 Uterine Cervical Neoplasms 4 Neoplasms 4 Thyroid Neoplasms 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Biliary Tract Neoplasms 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Sarcoma 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Castration-Resistant Prostate Cancer 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡